Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease

Haemophilia

Volumn 21, Issue 5, 2015, Pages 636-641

  Rydz, Natalia ^a   Grabell, J ^a   Lillicrap, D ^a   James, P D ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Ageing; Bleeding; Haemostasis; Von Willebrand Disease

Indexed keywords

BLOOD CLOTTING FACTOR 8; VON WILLEBRAND FACTOR;

ADULT; AGE; AGED; AGING; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VON WILLEBRAND DISEASE; METABOLISM; MIDDLE AGED;

ADULT; AGE FACTORS; AGED; FACTOR VIII; FEMALE; HUMANS; MALE; MIDDLE AGED; VON WILLEBRAND DISEASE, TYPE 1; VON WILLEBRAND FACTOR;

EID: 84942194089     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12664     Document Type: Article

References (30)

1. Franchini M. Hemostasis and aging. Crit Rev Oncol Hemat 2006; 60: 144-51.
2. Balleisen L, Bailey J, Epping PH et al. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population: I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using, and menopause. Thromb Haemost 1985; 54: 475-9.
3. Kannel WB, Wolf PA, Castelli WP et al. Fibrinogen and risk of cardiovascular disease. The Framingham Study. J Am Med Assoc 1987; 258: 1183-6.
4. Hager K, Setzer J, Vogl T et al. Blood coagulation factors in the elderly. Arch Gerontol Geriat 1989; 9: 277-82.
5. Denis CV, Christophe OD, Oortwijn BD et al. Clearance of von Willebrand factor. Thromb Haemost 2008; 99: 271-8.
6. Dolan G, Neal K, Cooper P et al. Protein C, antithrombin III and plasminogen: effect of age, sex and blood group. Brit J Haematol 1994; 86: 798-803.
7. Lowe GD, Rumley A, Woodward M et al. Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use. Brit J Haematol 1997; 97: 775-84.
8. Stout RW, Crawford VL, McDermott MJ et al. Seasonal changes in haemostatic factors in young and elderly subjects. Age Ageing 1996; 25: 256-8.
9. Cadroy Y, Daviaud P, Saivin S et al. Distribution of 16 hemostatic laboratory variables assayed in 100 blood donors. Nouv Rev Fr Hematol 1990; 32: 259-64.
10. Bauer KA, Weiss LM, Sparrow D et al. Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study. J Clin Invest 1987; 80: 1527-34.
11. Tracy RP, Arnold AM, Ettinger W, et al. The Relationship of Fibrinogen and Factors VII and VIII to Incident Cardiovascular Disease and Death in the Elderly?: results From the Cardiovascular Health Study. Arterioscl Throm Vas 1999; 19: 1776-83.
12. Mari D, Coppola R, Provenzano R. Hemostasis factors and aging. Exp Gerontol 2008; 43: 66-73.
13. Bauer KA, Kass BL, Ten Cate H et al. Factor IX is activated in vivo by the tissue factor mechanism. Blood 1990; 76: 731-6.
14. Cadroy Y, Pierrejean D, Fontan B et al. Influence of aging on the activity of the hemostatic system: prothrombin fragment 1 + 2, thrombin-antithrombin III complexes and D-dimers in 80 healthy subjects with age ranging from 20 to 94 years. Nouv Rev Fr Hematol 1992; 34: 43-6.
15. Miesbach W, Alesci S, Krekeler S et al. Age-dependent increase of FVIII: C in mild haemophilia A. Haemophilia 2009; 15: 1022-6.
16. Miesbach W, Alesci S, Krekeler S et al. Comorbidities and bleeding pattern in elderly haemophilia A patients. Haemophilia 2009; 15: 894-9.
17. Conlan MG, Folsom AR, Finch A et al. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 1993; 70: 380-5.
18. Coppola R, Mari D, Lattuada A. von Willebrand factor in Italian centenarians. Haematologica 2003; 88: 39-43.
19. Kadir RA, Economides DL, Sabin CA et al. Variations in coagulation factors in women: effects of age, ethnicity, menstrual cycle and combined oral contraceptive. Thromb Haemost 1999; 82: 1456-61.
20. Kokame K, Sakata T, Kokubo Y et al. von Willebrand factor-to-ADAMTS13 ratio increases with age in a Japanese population. J Thromb Haemost 2011; 9: 1426-8.
21. James PD, Notley C, Hegadorn C et al. The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study. Blood 2007; 109: 145.
22. Bowman M, Mundell G, Grabell J et al. Generation and validation of the Condensed MCMDM-1VWD Bleeding Questionnaire for von Willebrand disease. J Thromb Haemost 2008; 6: 2062-6.
23. Sadler JE, Mannucci PM, Berntorp E et al. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost 2000; 84: 160-74.
24. Van den Burg PJM, Hospers JEHJ, Mosterd WLW et al. Aging, physical conditioning, and exercise-induced changes in hemostatic factors and reaction products. J Appl Physiol 2000; 88: 1558.
25. Ribeiro J, Almeida-Dias A, Ascensão A et al. Hemostatic response to acute physical exercise in healthy adolescents. J Sci Med Sport 2007; 10: 164-9.
26. Goodeve A, Eikenboom J, Castaman G et al. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD). Blood 2007; 109: 112-21.
27. Barr RD, Sek J, Horsman J et al. Health status and health-related quality of life associated with von Willebrand disease. Am J Hematol 2003; 73: 108-14.
28. De Wee EM, Mauser-Bunschoten EP, Van Der Bom JG et al. Health-related quality of life among adult patients with moderate and severe von Willebrand disease. J Thromb Haemost 2010; 8: 1492-9.
29. Nichols WL, Hultin MB, James AH et al. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia 2008; 14: 171-232.
30. Tosetto A, Rodeghiero F, Castaman G et al. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost 2006; 4: 766-73.